Dow Up 1.31% Nasdaq Up 2.40%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.16 Down 0.01(0.24%) 4:00PM EDT
Prev Close:4.17
Open:4.21
Bid:4.11 x 800
Ask:4.40 x 2000
1y Target Est:6.57
Beta:-3.58
Earnings Date:Oct 27 - Nov 6 (Est.)
Day's Range:4.15 - 4.31
52wk Range:3.26 - 7.97
Volume:3,193,899
Avg Vol (3m):4,454,060
Market Cap:914.51M
P/E (ttm):N/A
EPS (ttm):-0.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNADown 0.24%914.51M
GSKUp 0.05%104.80B
OREXUp 11.08%552.63M
RHHBYUp 1.51%247.27B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback